Exagen Inc. Common Stock XGN
$4.53
-3.00%
at last close
Financials (TTM)
- Revenue
- $68.38 million
- Net Income
- $-20,166,000
- Net Margin
- -29.49%
- Return on Equity
- -139.73%
- Debt-to-Equity
- 1.58
- P/E Ratio
- —
- Price / Book
- 7.58
- Price / Sales
- 1.60
Over the trailing twelve months, Exagen Inc. Common Stock generated revenue of $68.38 million and net income of $-20,166,000, a net margin of -29.49%.
At the last closing price of $4.53, XGN trades at 1.60 times sales, with a market capitalization of $109.44 million.
Key Stats
- Last Close
- $4.53
- Market Cap
- $109.44 million
- 52-Week Range
- $2.59 – $12.23
- Average Volume
- 218K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.